Phase 3 FRESCO-2 Trial Analysis of Fruquintinib mCRC Colorectal 3 Mins Read3 The phase 3 FRESCO-2 study evaluated the efficacy and safety of fruquintinib, a novel targeted therapy, in patients with advanced…
FRESCO-2 Trial Meets Endpoints: Metastatic Colorectal Cancer Colorectal 15 Mins Read3 FRESCO-2 Trial Met Primary Endpoints in Patients With Metastatic Colorectal announced HUTCHMED from the Fruquintinib Global Phase III Trial The…
